Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.
Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Karofi, D. H. Lawal, N. Bello, M. B. Imam, M. U.
Immunogenicity and Protective Efficacy of Nucleic Acid-Based Vaccines Against COVID-19: A Systematic Review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Katoto, P. D. Kakubu, M. A. Tamuzi, J. L. Brand, A. S. Ayuk, A. Byamungu, L. N. Wiysonge, C. S. Gray, G.
Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses
Adolescents Adults COVID-19 Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Li, P. Wang, W. Tao, Y. Tan, X. Li, Y. Mao, Y. Gao, L. Feng, L. Zhan, S. Sun, F.
Immunogenicity and reactogenicity of heterologous immunization schedules with COVID-19 vaccines: a systematic review and network meta-analysis
Adults COVID-19 Administration Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Cheng, M. Q. Li, R. Luo, X. Chen, J. Y. Bai, Z. P. Zhao, P. Weng, Z. Y. Song, G.
Immunogenicity and safety of adjuvant-associated COVID-19 vaccines: A systematic review and meta-analysis of randomized controlled trials
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Zhao, T. Yang, Z. Wu, Y. Yang, J.
Immunogenicity and safety of COVID-19 vaccines among people living with HIV: A systematic review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Carregaro, R. L. Roscani, A. N. C. P. Raimundo, A. C. S. Ferreira, L. Vanni, T. da Graça Salomão, M. Probst, L. F. Viscondi, J. Y. K.
Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
All age groups Influenza Safety Efficacy/effectiveness Administration
Rating:
High
2023 ∙ Nave, L. Margalit, I. Tau, N. Cohen, I. Yelin, D. Lienert, F. Yahav, D.
Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine-A Systematic Review and Meta-Analysis of Randomized Controlled Trials
All age groups Smallpox Mpox Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Wei, X. Tan, X. Guan, Q. Zhang, R. Lei, S. Wei, S.
Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
Newborn Children Influenza Efficacy/effectiveness Safety
Rating:
Low
2023 ∙ Marantos, T. Kyriazopoulou, E. Lekakis, V. Voumvourakis, K. I. Tsiodras, S.
Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis
Adults Efficacy/effectiveness Safety
Rating:
Critically low
Loading...